Aeglea Biotherapeutics shares owned by ProFund Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by ProFund Advisors
from 13F filings
Historical chart of ProFund Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by ProFund Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $222k | 13k | 16.76 |
| 2025-06-30 | $165k | 11k | 14.97 |
| 2025-03-31 | $237k | 15k | 16.14 |
| 2024-12-31 | $346k | 15k | 23.28 |
| 2024-09-30 | $414k | 14k | 29.41 |
| 2024-06-30 | $296k | 13k | 23.51 |